Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen and simvastatin as add-on therapy in schizophrenia and schizoaffective disorder
2013-000415-25Phase 3Completed
- Sponsor
- CliniRx
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naproxen and simvastatin in schizophrenia and schizoaffective disorder (4 arms), sponsored by CliniRx. Primary endpoint: PANSS total score at end of trial. Started Feb 2020; status: completed.
02
Drugs
naproxensimvastatin
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on 2013-000415-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000415-25.